Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

Clinical trial NCT05564416 · WITHDRAWN

Trial details

NCT number: NCT05564416
Sponsor: National Cancer Institute (NCI)
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Carcinoma Bladder Urothelial Carcinoma Muscle Invasive Bladder Carcinoma Renal Pelvis and Ureter Urothelial Carcinoma Stage II Bladder Cancer AJCC v8 Stage III Bladder Cancer AJCC v8 Stage IVA Bladder Cancer AJCC v8 Urothelial Carcinoma

Start date: 2023-10-12
Primary completion: 2024-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.